Nuclear Regulation RedHill Biopharma Receives U.S. Patent Filing Grants for Opaganib and RHB-107 for COVID-19 – PRNewswire By Carmen Lillard On May 26, 2021 Share RedHill Biopharma Receives U.S. Patent Filing Approvals for Opaganib and RHB-107 for COVID-19 PRNewswire BiopharmaCOVID19FilinggrantsOpaganibPatentPRNewswirereceives Share
Comments are closed.